{"id":"https://openalex.org/W2015037490","doi":"https://doi.org/10.1016/j.bmcl.2012.10.034","title":"Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold","display_name":"Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold","alternate_titles":[],"publication_year":2012,"publication_date":"2012-10-15","ids":{"openalex":"https://openalex.org/W2015037490","doi":"https://doi.org/10.1016/j.bmcl.2012.10.034","mag":"2015037490","pmid":"https://pubmed.ncbi.nlm.nih.gov/23122820"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2012.10.034","doi":"https://doi.org/10.1016/j.bmcl.2012.10.034","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2012.10.034","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015037490"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056878608","display_name":"Martin Tremblay","orcid":"https://orcid.org/0000-0003-4413-5962","observed_orcids":["https://orcid.org/0000-0003-4413-5962"]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martin Tremblay","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5. martin.tremblay@boehringer-ingelheim.com","Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5. martin.tremblay@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I4210138665"]},{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042070195","display_name":"Pierre R. Bonneau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierre Bonneau","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108683551","display_name":"Yves Bousquet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yves Bousquet","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022665769","display_name":"Patrick DeRoy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick DeRoy","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113573050","display_name":"Jianmin Duan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jianmin Duan","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037575284","display_name":"Martin Duplessis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Duplessis","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078177483","display_name":"Alexandre Gagnon","orcid":"https://orcid.org/0000-0002-0242-0936","observed_orcids":["https://orcid.org/0000-0002-0242-0936"]},"institutions":[{"id":"https://openalex.org/I159129438","display_name":"Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al","ror":"https://ror.org/002rjbv21","country_code":"CA","type":"education","lineage":["https://openalex.org/I159129438","https://openalex.org/I49663120"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexandre Gagnon","raw_affiliation_strings":["Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al, D\u00e9partement de Chimie, C.P. 8888, Succ. Centre-Ville, Montr\u00e9al, Qu\u00e9bec, Canada H3C 3P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al, D\u00e9partement de Chimie, C.P. 8888, Succ. Centre-Ville, Montr\u00e9al, Qu\u00e9bec, Canada H3C 3P8","institution_ids":["https://openalex.org/I159129438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034876716","display_name":"Michel Garneau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Garneau","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055392759","display_name":"Nathalie Goudreau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nathalie Goudreau","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003528483","display_name":"Ingrid Guse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingrid Guse","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021144490","display_name":"Oliver Hucke","orcid":"https://orcid.org/0000-0003-1842-3426","observed_orcids":["https://orcid.org/0000-0003-1842-3426"]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Oliver Hucke","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075809748","display_name":"Stephen H. Kawai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen H. Kawai","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019586708","display_name":"Christopher T. Lemke","orcid":"https://orcid.org/0000-0001-9419-1511","observed_orcids":["https://orcid.org/0000-0001-9419-1511"]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher T. Lemke","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087882257","display_name":"Stephen W. Mason","orcid":"https://orcid.org/0000-0002-6662-9624","observed_orcids":["https://orcid.org/0000-0002-6662-9624"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen W. Mason","raw_affiliation_strings":["Bristol-Myers Squibb, Virology, 5 Research Parkway, Wallingford, CT 06492, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Virology, 5 Research Parkway, Wallingford, CT 06492, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032833120","display_name":"Bruno Simoneau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bruno Simoneau","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091104568","display_name":"Simon Surprenant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon Surprenant","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080775305","display_name":"Steve Titolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steve Titolo","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007739276","display_name":"Christiane Yoakim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138665","display_name":"Boehringer Ingelheim (Canada)","ror":"https://ror.org/031sxg258","country_code":"CA","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210138665"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christiane Yoakim","raw_affiliation_strings":["Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim (Canada) Ltd, Research & Development, Laval, Qu\u00e9bec, Canada H7S 2G5","institution_ids":["https://openalex.org/I4210138665"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5056878608"],"corresponding_institution_ids":["https://openalex.org/I4210138665"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.0073,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.84721722,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"22","issue":"24","first_page":"7512","last_page":"7517"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.04610000178217888,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capsid-assembly-inhibitors","display_name":"capsid assembly inhibitors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/site-selective-modification","display_name":"site-selective modification","score":0.675000011920929},{"id":"https://openalex.org/keywords/x-ray-crystal-structure","display_name":"X-ray crystal structure","score":0.675000011920929},{"id":"https://openalex.org/keywords/high-throughput-screening-hits","display_name":"high-throughput screening hits","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C202878990","wikidata":"https://www.wikidata.org/wiki/Q830465","display_name":"Capsid","level":3,"score":0.9238051176071167},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8919944763183594},{"id":"https://openalex.org/C2778484023","wikidata":"https://www.wikidata.org/wiki/Q415190","display_name":"Benzimidazole","level":2,"score":0.8570798635482788},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.8473528623580933},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5868209004402161},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.48561373353004456},{"id":"https://openalex.org/C2778659115","wikidata":"https://www.wikidata.org/wiki/Q243992","display_name":"Furan","level":2,"score":0.43748387694358826},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4293730556964874},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38213199377059937},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3390805125236511},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3156294524669647},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20606040954589844},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07575798034667969},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06702661514282227},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D036022","descriptor_name":"Capsid Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2012.10.034","doi":"https://doi.org/10.1016/j.bmcl.2012.10.034","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2012.10.034","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:23122820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23122820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.4000000059604645}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307856","display_name":"World Health Organization","ror":"https://ror.org/01f80g185"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1480583983","https://openalex.org/W1582990169","https://openalex.org/W1964022123","https://openalex.org/W1972147363","https://openalex.org/W1985667653","https://openalex.org/W2006771360","https://openalex.org/W2033637003","https://openalex.org/W2034897068","https://openalex.org/W2036372832","https://openalex.org/W2038616997","https://openalex.org/W2042516964","https://openalex.org/W2063702342","https://openalex.org/W2094692623","https://openalex.org/W2107066237","https://openalex.org/W2111673257","https://openalex.org/W2114385090","https://openalex.org/W2116893683","https://openalex.org/W2117091532","https://openalex.org/W2132513517","https://openalex.org/W2135035609","https://openalex.org/W2156696460","https://openalex.org/W2159539082","https://openalex.org/W2951365790"],"related_works":["https://openalex.org/W2313953763","https://openalex.org/W2063702342","https://openalex.org/W2426701344","https://openalex.org/W2132513517","https://openalex.org/W2039285600","https://openalex.org/W2066288117","https://openalex.org/W2080043305","https://openalex.org/W4283076364"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015037490","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
